Trospium Chloride

CAS 10405-02-4 11 current records 7 historicalSmall Molecule

Who holds supplier records for Trospium Chloride? 11 organisations hold a current record for Trospium Chloride: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (2), Switzerland (1), Germany (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Trospium Chloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/trospium-chloride

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Trospium Chloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Trospium Chloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Trospium Chloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
DR. PFLEGER ARZNEIMITTEL GMBH BambergDE
CEP 2019-079 - Rev 04
Trospium chloride, Code number 090925
Aug 2026Inspected Dec 2025
Germany
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2010-040 - Rev 06
Trospium chloride
May 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2018-013 - Rev 01
Trospium chloride
Oct 2024—
ENALTEC LABS PRIVATE LIMITED Navi MumbaiIN
R0-CEP 2020-350 - Rev 00
Trospium chloride
Feb 2023—
OLON S.P.A. RodanoIT
R1-CEP 2015-081 - Rev 00
Trospium chloride
Apr 2021—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
R1-CEP 2012-119 - Rev 00
Trospium chloride
Nov 2018—
SIEGFRIED EVIONNAZ SA EvionnazCH
R1-CEP 2009-213 - Rev 00
Trospium chloride
Dec 2016—
INTERPHARMA PRAHA, A.S. PrahaCZ
R1-CEP 2007-272 - Rev 00
Trospium chloride
Feb 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Trospium Chloride are no longer active. These show a past filing, not current supply.

Show all 7 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Trospium Chloride is an antimuscarinic agent used to treat overactive bladder by reducing urinary frequency, urgency, and incontinence. It relaxes the smooth muscles of the bladder by inhibiting parasympathetic nervous activity.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cholinergic Muscarinic Antagonist
Mechanism of action
Cholinergic Muscarinic Antagonists

Therapeutic areas

UrologyCholinergic Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Trospium Chloride?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Trospium Chloride: ALIVUS LIFE SCIENCES LTD (India), ENALTEC LABS PRIVATE LTD (India), Macleods Pharmaceuticals Ltd. (India), MSN Laboratories Private Limited (India), OLON SPA (Italy), SIEGFRIED EVIONNAZ SA (Switzerland), MAITHRI DRUGS PRIVATE LTD (India) and PROCOS SPA (Italy), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Trospium Chloride Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 22673), ENALTEC LABS PRIVATE LTD (DMF 28230, 21652), Macleods Pharmaceuticals Ltd. (DMF 27532), MSN Laboratories Private Limited (DMF 25881), OLON SPA (DMF 22776), SIEGFRIED EVIONNAZ SA (DMF 21400), MAITHRI DRUGS PRIVATE LTD (DMF 41847) and PROCOS SPA (DMF 22079) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Trospium Chloride records mean?

7 organisations have only inactive Type II DMFs for Trospium Chloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Trospium Chloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Trospium Chloride on the EDQM register, including DR. PFLEGER ARZNEIMITTEL GMBH Bamberg (DE), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), ENALTEC LABS PRIVATE LIMITED Navi Mumbai (IN), OLON S.P.A. Rodano (IT) and MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Trospium Chloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Trospium Chloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.